Metabolomics analysis of Xanthoceras sorbifolia husks protection of rats against Alzheimer's disease using liquid chromatography mass spectrometry.

The promising effect of Xanthoceras sorbifolia Bunge husks against Alzheimer's disease has attracted more and more attention; however, its therapeutic mechanism has been unclear. A metabolomics study of the husks on rat serum and brain was carried out. Cognitive impairment of rats was induced by D-galactose and amyloid β, and the result was evaluated by Morris water maze test and brain histological analysis. The metabolite profiling was performed through ultra-high-performance liquid chromatography time-of-flight mass spectrometry. Twelve potential biomarkers were identified in the rat serum and nineteen in the brain. All the biomarkers could be classified as amino acids, lipids, purines and bile acids. Both the husk extract and control drug, huperzine A, showed protective effect against the cognitive disorder induced by amyloid β, however, the husk extract exhibited significant effect on more targets, which included arachidonic acid, cholic acid, uric acid and citric acid etc., indicating the regulation of the husks of more pathways including neuroinflammation, energy metabolism and antioxidant ability. Triterpenoid saponins and polyphenols in the husks may contribute to the regulation of these pathways. This comprehensive study revealed the underlying therapeutic mechanism of the husks against Alzheimer's disease; some potential biomarkers for its clinical diagnosis were also provided.

• Publication year

  2019

• Venue

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

• Publication date

  2019-09-15

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.jchromb.2019.121739PMID 31430683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease

  2019cited by this paper
• Metabolic profiling of the effects of ginsenoside Re in an Alzheimer’s disease mouse model

  2018cited by this paper
• Integrated strategy based on high-resolution mass spectrometry coupled with multiple data mining techniques for the metabolic profiling of Xanthoceras sorbifolia Bunge husks in rat plasma, urine, and feces.

  2018cited by this paper
• Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms

  2018cited by this paper
• Purine‐related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology

  2018cited by this paper
• A time-of-flight mass spectrometry based strategy to fast screen triterpenoids in Xanthoceras sorbifolia Bunge husks for bioactive substances against Alzheimer's disease

  2018cited by this paper
• Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease

  2017cited by this paper
• Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

  2017cited by this paper
• Studies on diagnostic biomarkers and therapeutic mechanism of Alzheimer's disease through metabolomics and hippocampal proteomics

  2017cited by this paper
• Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease

  2017cited by this paper
• Branched-chain amino acids and Alzheimer’s disease: a Mendelian randomization analysis

  2017cited by this paper
• Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era

  2016cited by this paper
• Discovery of serum metabolites for diagnosis of progression of mild cognitive impairment to Alzheimer's disease using an optimized metabolomics method

  2016cited by this paper
• Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.

  2016cited by this paper
• High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer's disease

  2016cited by this paper
• Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC–MS-based metabonomics

  2016cited by this paper
• Unraveling Alzheimer’s: Making Sense of the Relationship between Diabetes and Alzheimer’s Disease

  2016cited by this paper
• LC/MS-based metabolomics strategy to assess the amelioration effects of ginseng total saponins on memory deficiency induced by simulated microgravity.

  2016cited by this paper
• Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer’s Disease

  2016cited by this paper
• Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.

  2016cited by this paper
• A Novel Strategy for Large-Scale Metabolomics Study by Calibrating Gross and Systematic Errors in Gas Chromatography-Mass Spectrometry.

  2016cited by this paper
• Barrigenol triterpenes from the husks of Xanthoceras sorbifolia Bunge and their antitumor activities

  2016cited by this paper
• Xanthoceras sorbifolia extracts ameliorate dendritic spine deficiency and cognitive decline via upregulation of BDNF expression in a rat model of Alzheimer's disease.

  2016cited by this paper
• The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

  2015cited by this paper
• Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.

  2015cited by this paper
• Simultaneous quantification of ten constituents of Xanthoceras sorbifolia Bunge using UHPLC-MS methods and evaluation of their radical scavenging, DNA scission protective, and α-glucosidase inhibitory activities.

  2015cited by this paper
• A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model.

  2015cited by this paper
• Determination of catecholamines and their metabolites in rat urine by ultra-performance liquid chromatography-tandem mass spectrometry for the study of identifying potential markers for Alzheimer's disease.

  2015cited by this paper
• Age-Related Alterations in the Metabolic Profile in the Hippocampus of the Senescence-Accelerated Mouse Prone 8: A Spontaneous Alzheimer's Disease Mouse Model

  2014cited by this paper
• Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1-42

  2014cited by this paper
• Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations.

  2013cited by this paper
• Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease

  2013cited by this paper
• Biodiesel production from Xanthoceras sorbifolia in China: Opportunities and challenges

  2013cited by this paper
• Xanthoceraside inhibits pro-inflammatory cytokine expression in Aβ25-35/IFN-γ-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-κB, and mitogen-activated protein kinase signaling pathways.

  2013cited by this paper
• Bioactive barrigenol type triterpenoids from the leaves of Xanthoceras sorbifolia Bunge.

  2013cited by this paper
• Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats.

  2013cited by this paper
• Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model.

  2012cited by this paper
• Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.

  2012cited by this paper
• Plasma metabonomics as a novel diagnostic approach for major depressive disorder.

  2012cited by this paper
• Xanthoceraside attenuates amyloid β peptide25–35-induced learning and memory impairments in mice

  2011cited by this paper
• The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia

  2011cited by this paper
• Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.

  2011cited by this paper
• A possible role of myristoylated alanine-rich C kinase substrate in endocytic pathway of Alzheimer’s disease

  2010cited by this paper
• Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer’s Disease

  2010cited by this paper
• Supercritical carbon dioxide extraction of seed oil from yellow horn (Xanthoceras sorbifolia Bunge.) and its anti-oxidant activity.

  2010cited by this paper
• Optimization of microwave-assisted extraction of triterpene saponins from defatted residue of yellow horn (Xanthoceras sorbifolia Bunge.) kernel and evaluation of its antioxidant activity

  2010cited by this paper
• Lipid metabolism and Alzheimer's disease: pathways and possibilities

  2009cited by this paper
• Amyloid-beta peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2.

  2008cited by this paper
• Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism

  2008cited by this paper
• Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

  2008cited by this paper
• Morris water maze: procedures for assessing spatial and related forms of learning and memory

  2006cited by this paper
• Fusion of mass spectrometry-based metabolomics data.

  2005cited by this paper
• Phenylacetylglycine, a putative biomarker of phospholipidosis: Its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model

  2004cited by this paper
• Applications of the Morris water maze in the study of learning and memory.

  2001cited by this paper
• Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration

  1999cited by this paper
• Ischemic cell death in brain neurons.

  1999cited by this paper
• Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

  1997cited by this paper
• Trafficking between glia and neurons of TCA cycle intermediates and related metabolites

  1997cited by this paper
• [Role of glutamate and excitotoxicity in neurologic diseases].

  1996cited by this paper

• Network pharmacology to elucidate the role of phytotherapy in neurocognitive disorders.

  2025cites this paper
• Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

  2023cites this paper
• Shuganheweitang Ameliorates Chronic Unpredictable Mild Stress-Induced Depression-Like Behaviors in Rats through the PI3K/AKT/mTOR Pathway: Involvement of Amino Acids, Glycerophospholipids, and Energy Metabolism

  2023cites this paper
• Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer's disease

  2023cites this paper
• GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect of Xanthoceras sorbifolia Extract on Alzheimer's Disease in Mice

  2022cites this paper
• An integrated study on the comprehensive mechanism of Schisandra chinensis polysaccharides mitigating Alzheimer's disease in rats using a UPLC-Q-TOF-MS based serum and urine metabolomics strategy.

  2022cites this paper
• Phenolic composition and neuroprotective effects of the ethyl-acetate fraction from Inonotus sanghuang against H2O2-induced apoptotic cell death of primary cortical neuronal cells

  2022cites this paper
• Inhibition of gene expression and production of iNOS and TNF-α in experimental model of neurodegenerative disorders stimulated microglia by Soy nano-isoflavone/stem cell-exosomes.

  2022cites this paper
• Oriented Deep Eutectic Solvents as Efficient Approach for Selective Extraction of Bioactive Saponins from Husks of Xanthoceras sorbifolia Bunge

  2022cites this paper
• The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke

  2022cites this paper
• Xanthoceras sorbifolium Bunge: A Review on Botany, Phytochemistry, Pharmacology, and Applications

  2021cites this paper
• Chemical constituents from shells of Xanthoceras sorbifolium.

  2020cites this paper
• The protective effect of Xanthoceras sorbifolia Bunge husks on cognitive disorder based on metabolomics and gut microbiota analysis.

  2020cites this paper